Connecture, Inc. Drives Record Member Enrollment for Memorial Hermann Health Solutions
Apr 19, 2016 12:00 pm UTC| Business
BROOKFIELD, Wis., April 19, 2016 -- Connecture, Inc. (NASDAQ:CNXR), a provider of web-based information systems used to create health insurance marketplaces, announced use of its consumer-centric exchange platform...
The Tile Shop Reports First Quarter 2016 Results; Raises Full Year Outlook
Apr 19, 2016 12:00 pm UTC| Business
13.2% Comparable Store Sales Growth70.5% Gross Margin63.4% Operating Income Growth22.8% Adjusted EBITDA Margin and 31.3% Adjusted EBITDA Growth Diluted Earnings per Share of $0.13, growth of 85.7%Non-GAAP Diluted Earnings...
Melinta Therapeutics Appoints Dr. Eugene Sun as Chief Executive Officer
Apr 19, 2016 12:00 pm UTC| Business
NEW HAVEN, Conn, April 19, 2016 -- The Board of Directors of Melinta Therapeutics today announced that Eugene Sun, M.D., has been appointed Melinta’s Chief Executive Officer and member of the Board of Directors, making...
Shopoff Realty Investments Announces Appointment of Chief Financial Officer
Apr 19, 2016 12:00 pm UTC| Business
IRVINE, Calif., April 19, 2016 -- Shopoff Realty Investments, an Irvine, California-based manager of opportunistic and value-add real estate investments, announced today that the company has appointed Lisa Jack as chief...
Cuba Ventures Corp. Appoints Steve Marshall as CEO
Apr 19, 2016 12:00 pm UTC| Business
VANCOUVER, British Columbia, April 19, 2016 -- Cuba Ventures Corp. (TSX-V:CUV) (OTCBB:MPSFF) (Frankfurt:IJA2) (the “Company”) (formerly MPH Ventures Corp.) is pleased to announce that Steve Marshall has been appointed...
VBL Therapeutics Announces Publication of NASH Data for Lecinoxoids Molecules VB-201 and VB-703
Apr 19, 2016 12:00 pm UTC| Business
TEL AVIV, Israel, April 19, 2016 -- VBL Therapeutics (NASDAQ:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for cancer, today...
Apr 19, 2016 12:00 pm UTC| Business
CAMBRIDGE, Mass., April 19, 2016 -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will release its financial results for the...